Who’s Working on HIV Prevention?
Meet Estelle Piwowar-Manning - one of the many researchers working to cure the Human Immunodeficiency Virus (HIV)
Modern attempts to manage the spread of the virus responsible for AIDS has drastically minimised the incidence of this fatal illness. However, we are yet to cure HIV-related illnesses.
This hasn’t discouraged Estelle Piwowar-Manning, who is an active researcher in HIV prevention, investigating when it’s most resistant to drug therapy, what attitudes and behaviours promote the spread of HIV, and focusses on strategies and interventions that prevent HIV acquisition in at-risk populations.
Recently awarded the Staff Excellence in Leadership Award at the 2018 HIV Prevention Trials Network (HPTN) Annual Meeting, Piwowar-Manning is the Network Laboratory Deputy Director at Microbicide Trials Network (MTN).
At MTN, she was involved with the HPTN 035 trial, which was designed to assess the safety and effectiveness of two potential treatments of HIV in women. The full report of the trial is available on the PubMed website. While the STI prevention gels (called microbicides) were unsuccessful at preventing the tested STIs, the trial demonstrates the ongoing efforts in STI prevention research.